What Researchers Did
Researchers studied 12 healthy people exposed to air at 5 ATA for 48 hours in a hyperbaric chamber to observe the development of pulmonary oxygen toxicity, comparing it to previous studies using pure oxygen.
What They Found
Subjects experienced symptoms such as chest tightness, cough, and shortness of breath starting around 12 hours and lasting several days. Pulmonary function tests showed significant decreases in vital capacity, flow rates, and DLCO. While most subjects showed definite recovery within 8 days, some experienced fatigue and exertional dyspnea for up to a month; a control group exposed to 6% oxygen at 5 ATA showed none of these changes.
What This Means for Canadian Patients
This research helps understand pulmonary oxygen toxicity, a potential risk during hyperbaric oxygen therapy (HBOT) or deep diving. The findings can assist Canadian medical professionals in managing patient safety by emphasizing careful monitoring and adherence to HBOT protocols to reduce adverse effects. It highlights the importance of balancing therapeutic benefits with potential risks associated with oxygen exposure.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was conducted in 1987 with a small number of subjects, which may limit the generalizability of the findings to a broader and more diverse patient population.